Aripiprazole monotherapy in a patient with major depressive disorder

被引：2
|
作者：
Yokoyama, Yuichi [1 ]
Kitamura, Hideaki [1 ]
Someya, Toshiyuki [1 ]
机构：
[1] Niigata Univ, Grad Sch Med & Dent Sci, Dept Psychiat, Niigata 9518510, Japan
来源：
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY | 2010年 / 34卷 / 06期
关键词：
ADJUNCTIVE THERAPY; DOUBLE-BLIND; MULTICENTER; EFFICACY; SAFETY;
D O I：
10.1016/j.pnpbp.2010.04.008
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1124 / 1125
页数：2
相关论文
共 50 条
  • [21] Cytokine profile of patient with major depressive disorder
    Babusikova, E.
    Ondrejka, I.
    Hrtanek, I.
    Dobrota, D.
    JOURNAL OF NEUROCHEMISTRY, 2019, 150 : 81 - 81
  • [22] Comparison of lithium, aripiprazole and olanzapine as augmentation to paroxetine for inpatients with major depressive disorder
    Yoshimura, Reiji
    Hori, Hikaru
    Umene-Nakano, Wakako
    Ikenouchi-Sugita, Atsuko
    Katsuki, Asuka
    Atake, Kiyokazu
    Nakamura, Jun
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2014, 4 (03) : 123 - 129
  • [23] Aripiprazole augmentation for major depressive disorder: dosing patterns in a naturalistic treatment setting
    Pae, Chi-Un
    Wang, Sheng-Min
    Han, Changsu
    Lee, Soo-Jung
    Patkar, Ashwin A.
    Masand, Prakash S.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2014, 29 (02) : 116 - 119
  • [24] Major depressive disorder - understanding the patient journey
    Baune, B. T.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S48 - S49
  • [25] A Major Depressive Disorder in a Patient with Pseudobulbar Affect
    Espiridion, Eduardo D.
    Risos, Kyle N.
    CUREUS, 2018, 10 (12):
  • [26] Electrophysiological studies in the rat brain as the basis for aripiprazole augmentation in major depressive disorder
    Chernoloz, O.
    El Mansari, M.
    Blier, P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S251 - S251
  • [27] Aripiprazole augmentation for major depressive disorder: Dosing patterns in a naturalistic treatment setting
    Kim, J.
    Kim, S. -H.
    Pae, C. -U.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 99 - 99
  • [28] Open-label tiagabine monotherapy for major depressive disorder with anxiety
    Carpenter, LL
    Schecter, JM
    Tyrka, AR
    Mello, AF
    Mello, MF
    Haggarty, R
    Price, LH
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (01) : 66 - 71
  • [29] Monotherapy antidepressant: A thing of the past? Implications for the treatment of major depressive disorder
    Antai-Otong, Deborah
    PERSPECTIVES IN PSYCHIATRIC CARE, 2007, 43 (03) : 142 - 145
  • [30] Effect of aripiprazole monotherapy in a patient presenting with delayed sleep phase syndrome associated with depressive symptoms
    Suzuki, Hidenobu
    Hibino, Hiroyuki
    Inoue, Yuichi
    Mikami, Katsunaka
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2018, 72 (05) : 375 - 376
12345